Table 1.

Cases of onset arginine vasopressin deficiency in the context of COVID-19.

Age (years)	Male/Female	Time from COVID-19 diagnosis	Serum sodium	MRI findings	outcome	Reference
68	Male	During acute infection	Hypernatremia	No abnormality	Death	[50]
60	Female	8 weeks	Hypernatremia	Pituitary stalk thickening	Good response to DDAVP	[45]
44	Female	12 days	Normal sodium Concomitant CAI	No abnormality	Good evolution in hospital, lost to follow-up	[46]
28	Male	1 month	Hypernatremia	No abnormality	Concomitant myocarditis Good response to DDAVP	[47]
54	Female	6 weeks	High normal sodium	No abnormality	Good response to DDAVP	[48]
17	Male	3 weeks	Hypernatremia	Disappearance of the normal posterior pituitary bright spot	Good response to DDAVP	[53]

*CAI = central adrenal insufficiency; DDAVP = desmopressin